JPMorgan Starts Diplomat Pharmacy (DPLO) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Credit Suisse Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 9:25 AM ESTCredit Suisse initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWells Fargo Starts Diplomat Pharmacy (DPLO) at Market Perform
November 19, 2014 8:50 AM ESTWells Fargo initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with a Market Perform rating and a price target of $24-$26.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWilliam Blair Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:35 AM ESTWilliam Blair initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreLeerink Swann Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:28 AM ESTLeerink Swann initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... More